Clinical Trial of TQB2858 Injection in the Treatment of Advanced High-grade Sarcoma

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This study is a single-arm, open-label, multicenter Phase Ib clinical trial evaluating TQB2858 injection in the treatment of advanced high-grade sarcoma. To evaluate the preliminary efficacy and safety of TQB2858 injection in patients with advanced high-grade sarcoma, and to explore the relevant biomarkers of TQB2858 injection.
Epistemonikos ID: e8e04e668b544918737a1b8b8e0f6acb96632826
First added on: May 10, 2024